Naime Majidi Zolbanin

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Cell Proliferation

Vascular Endothelial Growth Factor

Top Venues

Medical oncology (Northwood, London, England)

Clinical and experimental medicine

Advanced pharmaceutical bulletin

Urmia University of Medical Sciences, School of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Urmia University of Medical Sciences, School of Pharmacy Feb 13 2019

Iran

Assistant Professor :: Pharmacology & Toxicology

Publications

Mohaddeseh Hedayat, Mohammad Rafi Khezri, Reza Jafari, Hassan Malekinejad, Naime Majidi Zolbanin
Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells. Medical oncology (Northwood, London, England) 40 (9) (2023)
Mohaddeseh Hedayat, Reza Jafari, Naime Majidi Zolbanin
Selumetinib: a selective MEK1 inhibitor for solid tumor treatment. Clinical and experimental medicine (2022)
Naime Majidi Zolbanin, Reza Jafari, Jafar Majidi, Fatemeh Atyabi, Mehdi Yousefi, Farhad Jadidi-Niaragh, Leili Aghebati Maleki, Dariush Shanehbandi, Mohammad-Sadegh Soltani Zangbar, Alireza Mohajjel Nayebi
Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells. Advanced pharmaceutical bulletin 8 (3) (2018)